Russia Considers Ban on E-cigarette Additives: Industry Voices Concerns

Aug.09.2023
Russia Considers Ban on E-cigarette Additives: Industry Voices Concerns
Russia's Health Ministry is set to introduce a bill prohibiting certain additives in e-cigarettes, including nicotine salts and flavorings.

In a press conference, Artyom Metchelyov, Chairman of the Youth Policy Committee of the State Duma of Russia, announced that the Russian Ministry of Health will soon submit a bill to the Russian Cabinet for review, which aims to ban the use of additives in e-cigarettes.


This list of substances banned from increasing the appeal of nicotine-containing liquids includes:


Food additives, herbal flavoring agents, and their derivatives, including vanillin, cocoa and its derivatives, licorice, spices, and any natural flavorings are prohibited. Synthetic sugars and synthetic or natural sweeteners are also prohibited. Additionally, additives that enhance nicotine addiction, such as nicotine salts, ethanol, ammonium, and ammonia, are banned.


According to a report from the Russian newspaper "News Report" on August 8th, the Russian Union of Nicotine-Containing Product Industry (Союз предприятий индустрии никотиносодержащих изделий, abbreviated as СПИНИ) and the Professional Alliance of Participants in the Russian Market of Electronic Nicotine Systems (Профессиональный альянс участников русского рынка электронных никотиновых систем, abbreviated as ПАУРРЭНС) have sent a letter to Russian Finance Minister Anton Siluanov, requesting the removal of food flavorings and salt-based nicotine from the list of banned substances and additives.


This letter has received support from over 50 industry professionals and experts in the e-cigarette sector. Among them is Lev Grigoriev, Chairman of BABYLON, a leading e-cigarette compliant distributor in Russia, who also opposes the policy change.


Lev Grigoriev stated:


Flavorings are used in all e-cigarette liquids, many of which are not noticeable. Many flavorings are processed using technology and without them, the product would be unusable. In other words, it is illogical to completely ban all flavorings as there is no similar situation in the world.


The Ministry of Health recommends exclusively using liquid products containing propylene glycol and glycerol, much like suggesting a complete ban on all types of alcohol such as wine, liquor, brandy, and so on, and only utilizing pure ethanol.


The second recommendation concerns nicotine salts. What are nicotine salts? From a chemical standpoint, they are simply nicotine. So why does the Ministry of Health believe they can be addictive? Addiction is not caused by nicotine itself, but rather by its concentration.


The recommendation from the Ministry of Health is unlikely to solve the problem it claims to address - reducing the accessibility of nicotine products for minors and teenagers. Examples of similar bans include snus, a tobacco product in Sweden. Although snus is still available on the market, it is supplied illegally without the payment of taxes. This significantly impacts consumers who may be exposed to low-quality and unsafe products. Similarly, if the use of nicotine salts and flavorings is prohibited, the situation would likely be comparable.


What are the recommendations from industry experts regarding the market? It is not to completely ban all flavors, as e-cigarettes are composed of various substances.


Taking into account that minors make up approximately 11.2% of all e-cigarette consumers, we are actively striving to restrict accessibility to underage individuals. However, under the current circumstances, this measure would affect around 90% of adult users.


References:


[1] The business sector has requested not to ban the use of flavorings in vaping products. [2] Vape sellers are requesting not to ban flavorings.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | JNR Launches Shisha Hookah 70K E-Hookah With 60ml E-Liquid and 0.6% Nicotine
Product | JNR Launches Shisha Hookah 70K E-Hookah With 60ml E-Liquid and 0.6% Nicotine
JNR has introduced the Shisha Hookah 70K, a high-capacity rechargeable disposable vape designed around a hookah-inspired experience. The device comes prefilled with 60ml of e-liquid at 6mg/ml (0.6%) nicotine strength, alongside a 1,000mAh rechargeable battery and a 0.38Ω single mesh coil. It also features adjustable airflow and battery and e-liquid level displays. JNR claims the device can deliver up to 70,000 puffs and offers more than 20 flavors. Retail listings for the product have appeared in markets including Tunisia.
Market
Aug.24 by 2Firsts Perspectives
EU ‘TPD3’ Enters Next Phase on Aug. 14 as Fragmented Vape and Nicotine Pouch Rules Push the Single Market Toward Regulatory Overhaul
EU ‘TPD3’ Enters Next Phase on Aug. 14 as Fragmented Vape and Nicotine Pouch Rules Push the Single Market Toward Regulatory Overhaul
A 12-week European Commission consultation on revising the Tobacco Products Directive and Tobacco Advertising Directive is due to close on Aug. 14, 2026. The Commission has identified e-cigarette flavours, disposable vapes, tobacco heating devices, nicotine pouches, nicotine-free e-cigarettes, packaging and digital marketing among areas for possible new EU rules. National regulations already vary significantly across the bloc, a fragmentation the Commission says creates internal-market barriers and distorts competition. No formal revised TPD/TAD legislative text has yet been published, with the Commission currently indicating December 2026 for the legislative initiative.
Aug.14
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
Ahead of the Formula 1 race in Madrid, 67 Spanish and international public-health, medical and consumer organizations have sent an open letter to F1 President and CEO Stefano Domenicali calling for an end to sponsorships linked to the tobacco and nicotine industry, including nicotine pouches, vaping products and heated tobacco. The letter focuses on Philip Morris International’s ZYN partnership with Ferrari and British American Tobacco’s long-running partnership with McLaren and exposure for VELO. The campaign follows a March letter in which more than 160 organizations worldwide made a similar request to Formula 1.
Sep.10
Ireland’s Vape Tax Raises €22 Million in Nine Months as Government Considers 2027 Budget Changes
Ireland’s Vape Tax Raises €22 Million in Nine Months as Government Considers 2027 Budget Changes
According to Irish media outlets Highland Radio and BreakingNews.ie, the Irish government is considering whether to adjust vape tax policy in the 2027 Budget. The tax has generated about €22 million ($24 million) in revenue during its first nine months. While no increase has been confirmed, the revenue performance could influence future fiscal discussions. Any tax rise could increase product costs and potentially affect retail prices.
Aug.12
 PMI Opens Generative AI Center in Portugal to Support Global Operations
PMI Opens Generative AI Center in Portugal to Support Global Operations
According to information released by Portugal’s Trade & Investment Agency (AICEP) in July 2026, Philip Morris International (PMI) has established a global Generative Artificial Intelligence Factory (GenAI Factory) at its Portuguese subsidiary Tabaqueira. The center will support PMI’s global operations by developing and deploying AI solutions focused on industrial process optimization, data analytics, operational automation and AI application development. The initiative strengthens Portugal’s role in PMI’s global technology and innovation network.
Aug.27